Pfizer begins Phase 2 and 3 trial of Covid-19 antiviral Paxlovid in children ages 6 to 17

Pfizer begins Phase 2 and 3 trial of Covid-19 antiviral Paxlovid in children ages 6 to 17

Pfizer has begun a Phase 2 and 3 clinical trial of its Covid-19 antiviral treatment, Paxlovid, in children ages 6 to 17, the company said Wednesday in a news release.

Pfizer Begins Phase 2 And 3 Trial Of COVID-19 Antiviral Paxlovid In Children Ages 6 To 17

(CNN) — Pfizer has begun a Phase 2 and 3 clinical trial of its COVID-19 antiviral treatment, Paxlovid, in children ages 6 to 17, the company said Wednesday in a news release.The study will evaluate the safety and efficacy of the treatment in children who have COVID-19 symptoms and a confirmed infection, who are not hospitalized and who are at risk of severe disease.Paxlovid is already authorized by the US Food and Drug Administration for high-ri…

Pfizer launches clinical trial testing its COVID-19 pill in children aged 6 and older

Pfizer announced Wednesday it is launching a clinical trial to study the effectiveness of its COVID-19 antiviral pill in young children.

Pfizer launches clinical trial testing its COVID-19 pill in children aged 6 and older

Pfizer announced Wednesday it is launching a clinical trial to study the effectiveness of its COVID-19 antiviral pill in young children.

Pfizer begins Phase 2 and 3 trial of Covid-19 antiviral Paxlovid in children ages 6 to 17

Pfizer has begun a Phase 2 and 3 clinical trial of its Covid-19 antiviral treatment, Paxlovid, in children ages 6 to 17, the company said Wednesday in a news release.

Pfizer begins Phase 2 and 3 trial of Covid-19 antiviral Paxlovid in children ages 6 to 17

By Amanda Sealy, CNN    (CNN) -- Pfizer has begun a Phase 2 and 3 clinical trial of its Covid-19 antiviral treatment, Paxlovid, in children ages 6 to 17, the company said Wednesday in a news release.T